We demonstrated the role of HNRNPC in tumorigenesis and its function in regulating IRAK1 mRNA stability in an m6A-dependent manner, which was necessary for the malignant behavior of glioma cells by resulting in activation of the MAPK signaling pathway. The gene discussed is HNRNPC; the disease is central nervous system cancer.